In conclusion, this exploratory post hoc analysis of participants with ICH from the i-DEF randomized trial identified novel signals for an association of Hb with PHE, which warrant further exploration in future research investigating anemia as a potential treatment target for ICH. This evidence concerns the gene GSTM1 and anemia (phenotype).